| Literature DB >> 26902451 |
Hae-Young Lee1, Sang Hong Baek.
Abstract
Beta-blockers are the cornerstone treatment for congestive heart failure (HF). Current HF guidelines commonly recommend β-blockers for the treatment of HF with reduced left ventricular ejection fraction (LVEF). The effect of β-blockers, however, is less clear for HF patients with preserved LVEF, unstable severe acute HF, or right ventricular failure. This review summarizes the effect of β-blockers in various clinical situations and suggests a strategy for optimal use. (Circ J 2016; 80: 565-571).Entities:
Mesh:
Substances:
Year: 2016 PMID: 26902451 DOI: 10.1253/circj.CJ-16-0101
Source DB: PubMed Journal: Circ J ISSN: 1346-9843 Impact factor: 2.993